Gö 6983 Exerts Cardioprotective Effects in Myocardial Ischemia/Reperfusion

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 5, 2004, Pages 645-656

  Peterman, Ellen E ^a   Taormina II, Philip ^a   Harvey, Margaret ^a   Young, Lindon H ^a  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

+dP dtmax; Endothelial dysfunction; Ischemia reperfusion; Left ventricular developed pressure; Neutrophils; Superoxide radicals

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; PROTEIN KINASE C; SUPEROXIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME INHIBITION; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT;

ANIMALS; CARBAZOLES; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART; MALE; MODELS, BIOLOGICAL; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 2042458414     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200405000-00006     Document Type: Article

References (43)

1. Kloner RA, Ellis SG, Lange R, et al. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure, and microvascular damage. Circulation. 1985;58:1-8.
2. Romson JL, Hook BG, Kunkel SL, et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67:1016-1023.
3. Mullane KM, Read N, Salmon JA, et al. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther. 1984;228:510-522.
4. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol. 1986;26:201-224.
5. Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol. 1990;259:H1660-H1666.
6. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc Res. 1996;32:743-751.
7. Tsao PS, Aoki N, Lefer DJ, et al. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402-1412.
8. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol. 1989;21:1241-1251.
9. Shandelya S, Kuppusamy P, Wesfeldt M, et al. Evaluation of the role of Polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury: Evidence for plasma-mediated leukocyte activation. Circulation. 1993;87:536-546.
10. Buerke M, Weyrich AS, Lefer AM. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. Am J Physiol. 1994;266:H128-H136.
11. Rubanyi GM, Vanhoutte P. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol. 1986;250: H815-H821.
12. Ma XL, Tsao PS, Viehman GE, et al. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfusion cat coronary artery. Circ Res. 1991;69:95-106.
13. Ma XL, Weyrich AS, Lefer DJ, et al. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72:403-412.
14. Bednar MSB, Pinto A, Mullane KM. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res. 1985;57:131-141.
15. Young LH, Ikeda Y, Scalia R, et al. Wortmannin, a potent antincutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion. J Pharmacol Exp Ther. 2000;295:37-43.
16. Laudanna C, Mochly-Rosen D, Liron T, et al. Evidence of zeta-PKC involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem. 1998;273:30306.
17. Rahman A, Anwar KN, Malik AB. Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells. Am J Physiol. 2000;279:C906-C914.
18. Dang P, Fontayne A, Hakim J, et al. Protein kinase C zeta phosphorylates a subset of selective sites of the NAPDH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol. 2001;166:1206-1213.
19. Young LH, Ikeda Y, Lefer A. Protein kinase inhibition exerts cardioprotective effects in myocardial ishemia/reperfusion via inhibition of superoxide release. Meth Find Exp Clin Pharmacol. 2001;23:107-114.
20. Numaguchi K, Shimokawa H, Nakaike R, et al. PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats. Am J Physiol. 1996;270:H1634-H1639.
21. Korchak HM, Rossi MW, Kilpatrick LE. Selective role for β-protein kinase C in signaling for O2-generation but not degranulation or adherence in differentiated HL60 cells. J Biol Chem. 1998;273:27292-27299.
22. Korchak HM, Kilpatrick LE. Roles for β11-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL60 cells. J Biol Chem. 2001;276:8910-8917.
23. Dekker LV, Leitges M, Altschuler G, et al. A Protein kinase C-β contributes to NADPH oxidase activation in neutrophils. Biochem J. 2000;347: 285-289.
24. Frey RS, Rahman A, Kefer JC, et al. PKC zeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res. 2002;90:1012-1019.
25. Stempka L, Girod A, Muller H, et al. Phosphorylation of protein kinase C delta (PKCdelta) at threonine 505 is not prerequisite for enzymatic activity. J Biol Chem. 1997;272:6805-6811.
26. Gschwendt M, Dieterich S, Rennecke J, et al. Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett. 1996;392:77-80.
27. Lasley R, Noble M, Mentzer R Jr. Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium. J Mol Cell Cardiol. 1997;29:3345-3356.
28. Ishii H, Jirousek MR, Daisuke K, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science. 1996:272:728-731.
29. Martiny-Baron G, Kazanietz M, Mischak H, et al. Selective inhibition of Protein Kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem. 1993;268:9194-9197.
30. Clerk A. Death by Protein Kinase C inhibitor: A stressful event. J Mol Cell Cardiol. 2001;33:1773-1776.
31. Lefer AM, Campbell B, Shin YK, et al. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation. 1999;100:178-184.
32. Ohlstein EH, Nicholas AJ. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res. 1989;65:917-924.
33. Scalia R, Murohara T, Delyani JA, et al. Myocardial protection by N,N,N-trimethylsphingosine in ischemia reperfusion injury is mediated by inhibition of P-selection. J Leukoc Biol. 1996;59:317-324.
34. Yan SR, Novak MJ. Diverse effects of neutrophil integrin occupation on respiratory burst activation. Cell Immunol. 1999;195:119-126.
35. Zhang J, Zhang M, Kazunori S, et al. D-eystathionine ketimine and L-cystathionine ketimine enhance superoxide generation by human neutrophils in a different manner. Arch Biochem Biophys. 1999;363:55-59.
36. Patel KD, Zimmerman GA, Prescott SM, et al. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 1991;112:749-759.
37. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-Selectin expression and actions in the rat microcirculation. Gastroenterology. 1994;107:1050-1058.
38. Gauthier TW, Davenpeck KL, Lefer AM. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol. 1994;267:G562-G568.
39. Strasser RH, Braun-Dullaeus R, Walendzik H, et al. Alpha1-Receptor-independent activation of protein kinase C in acute myocardial ischemia. Circ Res. 1992;70:1304-1312.
40. Rubanyi GM, Desiderio D, Luisi A, et al. Phobol dibutyratc inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels. J Pharmacol Exp Ther. 1989;249:858-863.
41. Zulueta JJ, Yu F-S, Hertig IA, et al. Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NADPH oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol. 1995;12:41-49.
42. Chen X, Catravas JD. Release of a leukocyte activation inhibitor by staurosporine-treated pulmonary artery endothelial cells. Am J Physiol. 1998;275:184-192.
43. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-157781.